Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Jeremy Grummet is a leading urological surgeon and researcher whose work is reshaping the diagnosis and treatment of prostate cancer. His primary research focuses on advancing transperineal prostate biopsy techniques and evaluating focal ablative therapies as alternatives to standard management. Dr. Grummet is a key advocate for the transperineal approach, which offers superior accuracy and safety compared to traditional transrectal methods, as highlighted in his highly-cited 2020 review (57 citations). He has also pioneered the use of robotic-assisted MRI/US fusion biopsy, demonstrating its precision with the iSR’obot Mona Lisa system. Beyond diagnostics, his systematic review on focal ablative therapy (52 citations) critically assesses the evidence for less invasive treatments, providing essential guidance for clinical practice. His work extends to renal cancer, where he compared robotic-assisted versus open partial nephrectomy (30 citations). With a portfolio of influential papers, including a high-throughput 3D organoid drug screening assay (67 citations), Dr. Grummet’s contributions are driving safer, more targeted interventions and improving outcomes for patients with urological cancers.